Here is a roundup of cancer treatments that were approved by the FDA in the spring of 2022 that patients may have missed.
Several cancer treatments received approvals from the Food and Drug Administration (FDA) in the spring.
The FDA approvals were indicated for drug combinations to treat solid tumors with certain genetic characteristics, as well as a biosimilar to treat neutropenia (lower-than-normal levels of neutrophils, which is a type of white blood cell).
Here, CURE® provides a rundown of the newer cancer therapies that the FDA approved this spring:
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.